A considerable percentage of patients with peripheral arterial disease (PAD) have impaired
renal function. We searched the literature (PubMed/Medline) to determine the clinical …

Highlights•Peripheral artery disease (PAD) is characterized by increased cardiovascular
risk.•Statins remain the first-line lipid-lowering therapy to treat PAD patients.•Statins …

Lower-extremity artery disease (LEAD) is one of the most frequent modes of clinical
presentation of atherosclerosis worldwide. 1 For the past four decades, the increased risk of …

Introduction Practice guidelines recommend that patients with peripheral artery disease
receive antiplatelets, statins, and angiotensin-converting enzyme (ACE) inhibitors or …

Introduction: Peripheral arterial disease (PAD) treatment guidelines recommend the use of
statins and antiplatelets in all PAD patients to reduce adverse cardiovascular and limb …

Objective Patients with peripheral artery disease (PAD) are at increased risk of major
adverse limb events (MALE). Furthermore, MALE have several clinical implications and a …

Objectives Physicians have poor knowledge of peripheral arterial disease (PAD).
Inadequate exposure to PAD in medical school curricula may by a contributing factor. The …

Women with peripheral arterial disease (PAD) have more limited physical function than men
but the mechanisms involved are not clear. We determined whether alterations in lipid …

Kosmas I. Paraskevas, MD, FASA, Theofanis T. Papas, MD, Polyvios Pavlidis, MD, Nikolaos
Bessias, MD, and Vassilios Andrikopoulos, MD of PAD. Ankle brachial pressure index …

Objectives. Observational studies and surveys have shown that lipid-lowering treatment is
not optimal neither with regard to number of patients treated nor with number of patients …